Aligns with Eton's Mission to Develop and Distribute Medicines that Have a Life Changing Impact for Patients with Ultra-rare Conditions
Acquisition to Bolster Eton’s Commercial Pediatric Endocrinology Portfolio
https://www.globenewswire.com/news-release/2024/10/03/2957549/0/en/Eton-Pharmaceuticals-Inc-to-Acquire-Increlex-mecasermin-injection-from-Ipsen.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.